Progressive multifocal leukoencephalopathy and natalizumab - Unforeseen consequences

被引：192
|
作者：
Berger, JR [1 ]
Koralnik, IJ
机构：
[1] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
[2] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 04期
关键词：
D O I：
10.1056/NEJMe058122
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：414 / 416
页数：3
相关论文
共 50 条
  • [41] Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
    Foley, J.
    Vermersch, P.
    Gold, R.
    Kappos, L.
    Olsson, T.
    Cadavid, D.
    Bozic, C.
    Richman, S.
    JOURNAL OF NEUROLOGY, 2011, 258 : 47 - 47
  • [42] Early onset of natalizumab-related progressive multifocal leukoencephalopathy
    Damasceno, A.
    von Glehn, F.
    Martinez, A. R. M.
    Longhini, A. L. F.
    Deus-Silva, L.
    Brandao, C. O.
    Santos, L. M. B.
    Damasceno, B. P.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (11) : 1397 - 1398
  • [43] Management of progressive multifocal leukoencephalopathy associated with natalizumab - possibilities and responsibility
    Holmoy, T.
    Hestvik, A. L. K.
    Vartdal, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (08) : E2 - E2
  • [44] Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
    Sorensen, Per Soelberg
    Bertolotto, Antonio
    Edan, Gilles
    Giovannoni, Gavin
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Kieseier, Bernd C.
    Montalban, Xavier
    Olsson, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (02) : 143 - 152
  • [45] Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
    Langer-Gould, A
    Atlas, SW
    Green, AJ
    Bollen, AW
    Pelletier, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04): : 375 - 381
  • [46] Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis
    di Ioia, M.
    Farina, D.
    De Luca, G.
    Travaglini, D.
    Di Tommaso, V.
    Pietrolongo, E.
    Lugaresi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S132 - S133
  • [47] Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use
    Tornatore, Carlo
    Clifford, David B.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 : S16 - S25
  • [48] Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
    Toorop, Alyssa A.
    van Lierop, Zoe Y. G.
    Strijbis, Eva E. M.
    Teunissen, Charlotte E.
    Petzold, Axel
    Wattjes, Mike P.
    Barkhof, Frederik
    de Jong, Brigit A.
    van Kempen, Zoe L. E.
    Killestein, Joep
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (01):
  • [49] Reply to "Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy"
    Dalla Costa, Gloria
    Martinelli, Vittorio
    Furlan, Roberto
    Comi, Giancarlo
    ANNALS OF NEUROLOGY, 2019, 86 (02) : 324 - 324
  • [50] Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI
    Wattjes, Mike P.
    Barkhof, Frederik
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (03) : 260 - 270
12345